Related Experiment Video
Updated: Jun 23, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
[Posterior reversible encephalopathy syndrome in children with hematological diseases]
N V Bronina1, I O Shchederkina1,2, A Yu Polushin3
1Morozov Children's City Clinical Hospital, Moscow, Russia.
Insights
Posterior reversible encephalopathy syndrome (PRES) in children with hematological diseases is often caused by multiple risk factors, not just high blood pressure. Severity correlates with the number of risk factors identified.
Area of Science:
- Pediatric Hematology
- Neurology
- Oncology
Context:
- Posterior reversible encephalopathy syndrome (PRES) is a neurological condition.
- PRES can occur in children undergoing chemotherapy (CT) or allogeneic hematopoietic stem cell transplantation (allo-HSCT).
- Identifying risk factors (RF) and severity is crucial for management.
Purpose:
- To assess the risk factors and severity grade of PRES in pediatric patients with hematological diseases.
- To analyze the association between RF and PRES severity.
- To understand the clinical presentation and MRI findings in pediatric PRES.
Summary:
- This study analyzed 35 PRES cases in 32 children treated with CT or allo-HSCT.
- Multiple risk factors (≥2) were present in most cases (94.3%).
- Key RF included hypertension (88.6%), CT/immunosuppressive therapy (IST) (82.8%), and steroid therapy (71.4%). Seizures (94.3%) and decreased consciousness (28.6%) were common. MRI showed vasogenic edema predominantly in temporal and occipital lobes. Severity correlated with RF number (p<0.05).
Impact:
- Highlights that PRES in pediatric hematology patients is multifactorial.
- Emphasizes the correlation between the number of risk factors and PRES severity.
- Informs clinical practice regarding PRES monitoring and management in this vulnerable population.
Objective:
To assess risk factors (RF) and severity grade of Posterior reversible encephalopathy syndrome (PRES) in children with hematological diseases.
Material And Methods:
We analyzed cases of PRES in children during chemotherapy (CT) and after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We estimated the following RF: arterial hypertension, steroid therapy, CT, immunosuppressive therapy (IST), infection and renal injury.
Results:
Thirty-five cases of PRES occurred in 32 patients (8 after allo-HSCT and 27 during CT) were included in this study. In the most of cases (94.3%), there were 2 and more RF. An increase in blood pressure level (88.6%), CT and IST (82.8%) administration, steroid therapy (71.4%) were the most significant for PRES development. Infectious process and the decline in renal function played a lesser role in this syndrome (31.4% and 14%). At the initial presentation of PRES, there were seizures (94.3%), a decrease of consciousness (28.6%), headache, vision disturbances and stomachache (20%). In the most of cases (91.4%), the 2nd and 3d grade according to the Common Terminology Criteria for Adverse Events (CTCAE 5.0) were observed. Brain magnetic resonance imaging (MRI) revealed the vasogenic edema of temporal (88.6%), occipital (74.3%), frontal (40%) lobes and the cerebellum (22.9%) more often than the cytotoxic edema (p=0.03). The cytotoxic edema was observed in the thalamus and the basal ganglia (2.9%) more often than in other parts of the brain (p<0.01).
Conclusion:
The majority of PRES cases are caused by more than two RF. Arterial hypertension does not have a leading role among its causes. There is a significant correlation between the grade of PRES according to CTCAE 5.0 score and RF number (p<0.05).
More Related Videos
05:52Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
Published on: October 28, 2022
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Hepatic Encephalopathy